2015 Kentucky Revised Statutes
311.964 Health care facility not to restrict use of laetrile -- Exception.

KY Rev Stat § 311.964 (2015) What's This?

Download as PDF 311.964 Health care facility not to restrict use of laetrile -- Exception. (1) (2) When amygdalin (laetrile) is prescribed or administered by a physician holding a regular license for the practice of medicine in the State of Kentucky and the patient has signed a written informed request form, except as provided in subsection (2) of this section, a hospital or other health care facility shall not restrict or forbid the use of amygdalin (laetrile) in the treatment of any malignancy, disease, illness or physical condition. If the federal government states that it will withdraw all federal funds from a health care facility for allowing amygdalin (laetrile) to be used within the facility, and if providing or allowing its use within the facility would jeopardize the receipt of federal funds for reimbursement for medicine or Medicaid for all persons within the facility, or any construction funds provided by the federal government under the Hill-Burton Hospital Construction Program or under Title XVI of the Public Health Services Act, the hospital or other health care facility may, notwithstanding the provisions of subsection (1) of this section, prohibit the use of amygdalin (laetrile) within its facility. Effective: July 15, 1980 History: Created 1980 Ky. Acts ch. 354, sec. 11, effective July 15, 1980.

Disclaimer: These codes may not be the most recent version. Kentucky may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.